Loading...
Search for: drug-safety
0.005 seconds

    Repurposing the drug, ivermectin, in COVID-19: toxicological points of view

    , Article European Journal of Medical Research ; Volume 27, Issue 1 , 2022 ; 09492321 (ISSN) Shirazi, F. M ; Mirzaei, R ; Nakhaee, S ; Nejatian, A ; Ghafari, S ; Mehrpour, O ; Sharif University of Technology
    BioMed Central Ltd  2022
    Abstract
    The global COVID-19 pandemic has affected the world’s population by causing changes in behavior, such as social distancing, masking, restricting people’s movement, and evaluating existing medication as potential therapies. Many pre-existing medications such as tocilizumab, ivermectin, colchicine, interferon, and steroids have been evaluated for being repurposed to use for the treatment of COVID-19. None of these agents have been effective except for steroids and, to a lesser degree, tocilizumab. Ivermectin has been one of the suggested repurposed medications which exhibit an in vitro inhibitory activity on SARS-CoV-2 replication. The most recommended dose of ivermectin for the treatment of... 

    Fabrication and evaluation of bioresorbable scaffolds for interventional cardiology application with sufficient drug release

    , Article Iranian Journal of Basic Medical Sciences ; Volume 25, Issue 3 , 2022 , Pages 372-382 ; 20083866 (ISSN) Sadeghabadi, A ; Sadrnezhaad, S. K ; Asefnejad, A ; Nemati, N. H ; Sharif University of Technology
    Mashhad University of Medical Sciences  2022
    Abstract
    Objective(s): Bioresorbable scaffolds have been advocated as the new generation in interventional cardiology because they could provide temporary scaffolds and then disappear with resorption. Although, the available stents in clinical trials exhibited biosafety, efficacy, no death, and no apparent thrombosis, Mg-substrate degradation on drug release has not been investigated. Materials and Methods: Therefore, more research has been needed to legitimize the replacement of current stents with Mg-based stents. UV-Vis spectrophotometer, scanning electron microscope (SEM), X-ray diffraction (XRD), pH measurement, H2 evolution, and corrosion tests determined the change in hybrid properties and... 

    Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes

    , Article AAPS Journal ; Volume 19, Issue 3 , 2017 , Pages 652-668 ; 15507416 (ISSN) Morales, J. O ; Fathe, K. R ; Brunaugh, A ; Ferrati, S ; Li, S ; Montenegro Nicolini, M ; Mousavikhamene, Z ; McConville, J. T ; Prausnitz, M. R ; Smyth, H. D. C ; Sharif University of Technology
    Springer New York LLC  2017
    Abstract
    Biologic products are large molecules such as proteins, peptides, nucleic acids, etc., which have already produced many new drugs for clinical use in the last decades. Due to the inherent challenges faced by biologics after oral administration (e.g., acidic stomach pH, digestive enzymes, and limited permeation through the gastrointestinal tract), several alternative routes of administration have been investigated to enable sufficient drug absorption into systemic circulation. This review describes the buccal, sublingual, pulmonary, and transdermal routes of administration for biologics with relevant details of the respective barriers. While all these routes avoid transit through the...